Deals
Exact Sciences Is Said to Be in Talks to Buy Genomic Health
- Cancer diagnostic deal may be announced as early as next week
- Takeover could value Genomic Health at about $2.8 billion
This article is for subscribers only.
Exact Sciences Corp. is in advanced talks to acquire Genomic Health Inc. for about $2.8 billion to bolster its cancer testing capabilities, people familiar with the matter said.
An agreement could be announced as early as next week, said the people, who asked not to be identified because negotiations are private. Discussions could still be delayed or fall apart, the people said.